Literature DB >> 23238516

Synthesis of 14',15'-dehydro-ritterazine Y via reductive and oxidative functionalizations of hecogenin acetate.

Yi Kou1, Young Cheun, Myong Chul Koag, Seongmin Lee.   

Abstract

An analog of ritterazine Y was synthesized from hecogenin acetate in 23 steps via functional group manipulations of hecogenin acetate. Preparation of the north G and south Y units and the late stage Guo-Fuchs asymmetric coupling of the both units afforded the ritterazine Y analog.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23238516     DOI： 10.1016/j.steroids.2012.10.021

Source DB:  PubMed          Journal:  Steroids        ISSN： 0039-128X            Impact factor:   2.668


  15 in total

1.  Ritterostatin GN 1N , a Cephalostatin-Ritterazine Bis-steroidal Pyrazine Hybrid, Selectively Targets GRP78.

Authors:  Andrew J Ambrose; Evelyne A Santos; Paula C Jimenez; Danilo D Rocha; Diego V Wilke; Paolo Beuzer; Josh Axelrod; Ananda Kumar Kanduluru; Philip L Fuchs; Hu Cang; Letícia V Costa-Lotufo; Eli Chapman; James J La Clair
Journal:  Chembiochem       Date:  2017-02-02       Impact factor: 3.164

2.  Population pharmacokinetics and individualized lobaplatin regimen for the treatment of Chinese small cell lung cancer in the elderly.

Authors:  Ying Cheng; Lin Wu; Xiaoqing Liu; Yanqiu Zhao; Chunling Liu; Qun Chen; Tao Sun; Qingshan Zheng
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.817

3.  A phase II study of biweekly oxaliplatin plus S-1 combination chemotherapy as a first-line treatment for patients with metastatic or advanced gastric cancer in China.

Authors:  Cheng Xiao; Jiong Qian; Yulong Zheng; Fang Song; Qiangfeng Wang; Haiping Jiang; Chenyu Mao; Nong Xu
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

4.  Clinical efficacy of oral immunoglobulin Y in infant rotavirus enteritis: Systematic review and meta-analysis.

Authors:  Xiaotong Wang; Lijun Song; Wenpan Tan; Wenchang Zhao
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

5.  Non-steroidal anti-inflammatory drugs and risk of mortality in lung cancer: A meta-analysis of 5 prospective cohorts studies.

Authors:  Yifei Chen; Lili Kang; Ying Zhu; Chuanhong Jing; Yifei Chen; Lili Kang; Ying Zhu
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

6.  The influence of interleukin 28B polymorphisms on the risk of hepatocellular carcinoma among patients with HBV or HCV infection: An updated meta-analysis.

Authors:  Shaoyou Qin; Jiangbin Wang; Changyu Zhou; Yan Xu; Yonggui Zhang; Xu Wang; Song Wang
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

7.  Reversal of multidrug resistance in leukemia cells using a transferrin-modified nanomicelle encapsulating both doxorubicin and psoralen.

Authors:  He-Wen Wang; Ke-Ling Ma; Hua Liu; Jia-Yun Zhou
Journal:  Aging (Albany NY)       Date:  2020-04-07       Impact factor: 5.682

8.  A twenty gene-based gene set variation score reflects the pathological progression from cirrhosis to hepatocellular carcinoma.

Authors:  Yan Lin; Rong Liang; Jiazhou Ye; Qian Li; Ziyu Liu; Xing Gao; Xuemin Piao; Rongyun Mai; Donghua Zou; Lianying Ge
Journal:  Aging (Albany NY)       Date:  2019-12-06       Impact factor: 5.682

9.  Systematic Elucidation of the Mechanism of Oroxylum indicum via Network Pharmacology.

Authors:  Junmin Chen; Jianyong Chen; Jingrong Lu
Journal:  Evid Based Complement Alternat Med       Date:  2020-07-14       Impact factor: 2.629

10.  Rapamycin protects chondrocytes against IL-18-induced apoptosis and ameliorates rat osteoarthritis.

Authors:  Jiapeng Bao; Zhonggai Chen; Langhai Xu; Lidong Wu; Yan Xiong
Journal:  Aging (Albany NY)       Date:  2020-03-17       Impact factor: 5.682
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.